Pegylated PTH as PTH receptor modulators and uses thereof

Details Pegylated PTH as PTH receptor modulators and uses thereof Pegylated PTH as PTH receptor modulators and uses thereof

2007-10-04

2010-10-26

Landsman, Robert (Department: 1646)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Hormone or other secreted growth regulatory factor,...

C514S012200, C530S324000

Reexamination Certificate

active

07820179

ABSTRACT:
Pharmaceutical compositions and methods are provided for the treatment and prevention of bone loss diseases including osteoporosis in a mammal.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4656250 (1987-04-01), Morita et al.
patent: 4771124 (1988-09-01), Rosenblatt et al.
patent: 5393869 (1995-02-01), Nakagawa et al.
patent: 5556940 (1996-09-01), Willick et al.
patent: 5717062 (1998-02-01), Chorev et al.
patent: 5747456 (1998-05-01), Chorev et al.
patent: 5814603 (1998-09-01), Oldenburg et al.
patent: 5840837 (1998-11-01), Krstenansky et al.
patent: 5856138 (1999-01-01), Fukuda
patent: 5955574 (1999-09-01), Dong
patent: 6110892 (2000-08-01), Barbier et al.
patent: 6316410 (2001-11-01), Barbier et al.
patent: 6472505 (2002-10-01), Condon et al.
patent: 6569993 (2003-05-01), Sledeski et al.
patent: 6756480 (2004-06-01), Kostenuik et al.
patent: 6921750 (2005-07-01), Dong
patent: 7022815 (2006-04-01), Gardella et al.
patent: 2004/0060386 (2004-04-01), Hsieh
patent: 2004/0220094 (2004-11-01), Skinner
patent: 2005/0009147 (2005-01-01), Bauer et al.
patent: 2005/0026839 (2005-02-01), Gardella
patent: 2005/0124537 (2005-06-01), Kostenuik et al.
patent: 2005/0148763 (2005-07-01), Sekimori et al.
patent: 2006/0058230 (2006-03-01), Chorev et al.
patent: 293158 (1988-05-01), None
patent: 477885 (1991-09-01), None
patent: 748817 (1996-06-01), None
patent: 1477496 (2004-11-01), None
patent: 63060940 (1988-03-01), None
patent: S 63-60940 (1988-03-01), None
patent: WO 94/02510 (1994-02-01), None
patent: WO 95/11988 (1995-05-01), None
patent: WO 96/40193 (1996-12-01), None
patent: WO 97/02834 (1997-01-01), None
patent: WO 98/05683 (1998-02-01), None
patent: WO 98/14478 (1998-04-01), None
patent: WO 98/30590 (1998-07-01), None
patent: WO 99/46283 (1999-09-01), None
patent: WO 99/52933 (1999-10-01), None
patent: WO 99/57139 (1999-11-01), None
patent: WO 0121643 (2001-03-01), None
patent: WO 0123521 (2001-04-01), None
patent: WO 0181415 (2001-11-01), None
patent: WO 03009804 (2003-02-01), None
patent: WO 03105772 (2003-12-01), None
patent: WO 2004060386 (2004-07-01), None
patent: WO 2004060965 (2004-07-01), None
patent: WO 2005072277 (2004-12-01), None
patent: WO 2004103273 (2005-08-01), None
Na, Dong Hee, et al., “Capillary Electrophoretic Characterization of PEGylated Human Parathyroid Hormone With Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry,”Analytical Biochemistry331:322-328, Aug. 14, 2004.
Branden, Carl, et al., “Introduction to Protein Structure,” p. 13-14, Garland Publishing, Inc., 1991.

Affiliated with

Also associated with

Rating

Pegylated PTH as PTH receptor modulators and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pegylated PTH as PTH receptor modulators and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pegylated PTH as PTH receptor modulators and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4175201